Expert Insights on the Potential for Triplet Regimens in RCC
September 18th 2018<br /> Shilpa Gupta, MD, assistant professor in the Hematology, Oncology, and Transplantation Division at the University of Minnesota, discusses the potential for triplet regimens in the treatment of patients with renal cell carcinoma.
Watch